Published in:
Open Access
01-12-2014 | Short report
Prophylactic and therapeutic effect of AZT/3TC in RT-SHIV infected Chinese-origin rhesus macaques
Authors:
Wei Wang, Nan Yao, Zhe Cong, Hong Jiang, Chuan Qin, Qiang Wei
Published in:
AIDS Research and Therapy
|
Issue 1/2014
Login to get access
Abstract
Background
The precise efficacy of nucleoside analogue reverse-transcriptase inhibitors (NRTIs) in preventing and inhibiting virus replication remains unknown in RT-SHIV infected Chinese-origin rhesus macaques (Ch RM).
Findings
Ch RM were inoculated intravenously with 200 TCID50 RT-SHIV and treated by gavage with NRTIs (20 mg AZT and 10 mg 3TC twice per day) for four consecutive weeks beginning at one hour, on day 217 or 297 post inoculation, respectively. Treatment with AZT/3TC inhibited transiently RT-SHIV replication during chronic infection, but did not significantly affect peripheral blood CD4+ T cells in macaques. Treatment with AZT/3TC at 1 hour post infection prevented RT-SHIV infection in two out of four animals during the 120-day observation period.
Conclusions
Therefore, the Ch RM model with RT-SHIV infection can be used to evaluate the efficacy of new NRTIs.